Significant advances in our understanding of the genes that underlie the most common HCS, hereditary breast and ovarian cancer (HBOC) and Lynch syndrome, have been made since the cloning of BRCA1 in 1994, yet no more than 1%–10% of individuals at risk for these syndromes have been identified [1–3]. Here, BRCA1 is linked to Lynch syndrome.